Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2) (original) (raw)

. 1991 Dec;49(6):1207–1218.

Abstract

We undertook clinical evaluation (32 cases) and molecular evaluation (31 cases) of unrelated patients affected with Smith-Magenis syndrome (SMS) associated with an interstitial deletion of band p11.2 of chromosome 17. Patients were evaluated both clinically and electrophysiologically for peripheral neuropathy, since markers showing close linkage to one form of Charcot-Marie-Tooth disease (CMT1A) map to this chromosomal region. The common clinical findings were broad flat midface with brachycephaly, broad nasal bridge, brachydactyly, speech delay, and hoarse, deep voice. Fifty-five percent of the patients showed clinical signs (e.g., decreased or absent deep tendon reflexes, pes planus or pes cavus, decreased sensitivity to pain, and decreased leg muscle mass) suggestive of peripheral neuropathy. However, unlike patients with CMT1A, these patients demonstrated normal nerve conduction velocities. Self-destructive behaviors, primarily onychotillomania and polyembolokoilamania, were observed in 67% of the patients, and significant symptoms of sleep disturbance were observed in 62%. The absence of REM sleep was demonstrated by polysomnography in two patients. Southern analysis indicated that most patients were deleted for five 17p11.2 markers--FG1 (D17S446), 1516 (D17S258), pYNM67-R5 (D17S29), pA10-41 (D17S71), and pS6.1-HB2 (D17S445)--thus defining a region which appears to be critical to SMS. The deletion was determined to be of paternal origin in nine patients and of maternal origin in six patients. The apparent random parental origin of deletion documented in 15 patients suggests that genomic imprinting does not play a role in the expression of the SMS clinical phenotype. Our findings suggest that SMS is likely a contiguous-gene deletion syndrome which comprises characteristic clinical features, developmental delay, clinical signs of peripheral neuropathy, abnormal sleep function, and specific behavioral anomalies.

1207

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ameen Sait M., Reddy B. S., Garg B. R. Onychotillomania. 2 case reports. Dermatologica. 1985;171(3):200–202. [PubMed] [Google Scholar]
  2. Ballabio A., Bardoni B., Carrozzo R., Andria G., Bick D., Campbell L., Hamel B., Ferguson-Smith M. A., Gimelli G., Fraccaro M. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10001–10005. doi: 10.1073/pnas.86.24.10001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barker D., Wright E., Nguyen K., Cannon L., Fain P., Goldgar D., Bishop D. T., Carey J., Baty B., Kivlin J. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987 May 29;236(4805):1100–1102. doi: 10.1126/science.3107130. [DOI] [PubMed] [Google Scholar]
  4. Burd L., Vesely B., Martsolf J., Kerbeshian J. Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet. 1990 Sep;37(1):97–99. doi: 10.1002/ajmg.1320370122. [DOI] [PubMed] [Google Scholar]
  5. Chance P. F., Bird T. D., O'Connell P., Lipe H., Lalouel J. M., Leppert M. Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet. 1990 Dec;47(6):915–925. [PMC free article] [PubMed] [Google Scholar]
  6. Colley A. F., Leversha M. A., Voullaire L. E., Rogers J. G. Five cases demonstrating the distinctive behavioural features of chromosome deletion 17(p11.2 p11.2) (Smith-Magenis syndrome). J Paediatr Child Health. 1990 Feb;26(1):17–21. doi: 10.1111/j.1440-1754.1990.tb02372.x. [DOI] [PubMed] [Google Scholar]
  7. Colver G. B. Onychotillomania. Br J Dermatol. 1987 Sep;117(3):397–399. doi: 10.1111/j.1365-2133.1987.tb04150.x. [DOI] [PubMed] [Google Scholar]
  8. Dobyns W. B., Curry C. J., Hoyme H. E., Turlington L., Ledbetter D. H. Clinical and molecular diagnosis of Miller-Dieker syndrome. Am J Hum Genet. 1991 Mar;48(3):584–594. [PMC free article] [PubMed] [Google Scholar]
  9. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  10. Francke U., Harper J. F., Darras B. T., Cowan J. M., McCabe E. R., Kohlschütter A., Seltzer W. K., Saito F., Goto J., Harpey J. P. Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet. 1987 Mar;40(3):212–227. [PMC free article] [PubMed] [Google Scholar]
  11. Franco B., Lai L. W., Patterson D., Ledbetter D. H., Trask B. J., van den Engh G., Iannaccone S., Frances S., Patel P. I., Lupski J. R. Molecular characterization of a patient with del(1)(q23-q25). Hum Genet. 1991 Jul;87(3):269–277. doi: 10.1007/BF00200903. [DOI] [PubMed] [Google Scholar]
  12. Franco B., Rincon-Limas D., Nakamura Y., Patel P. I., Lupski J. R. Two MspI RFLPs at the D17S258 locus. Nucleic Acids Res. 1990 Dec 11;18(23):7196–7196. doi: 10.1093/nar/18.23.7196-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Guzzetta V., Montes de Oca-Luna R., Lupski J. R., Patel P. I. Isolation of region-specific and polymorphic markers from chromosome 17 by restricted Alu polymerase chain reaction. Genomics. 1991 Jan;9(1):31–36. doi: 10.1016/0888-7543(91)90217-3. [DOI] [PubMed] [Google Scholar]
  14. Hall J. G. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet. 1990 May;46(5):857–873. [PMC free article] [PubMed] [Google Scholar]
  15. Hamill M. A., Roberts S. H., Maguire M. J., Laurence K. M. Interstitial deletion of 17p11.2: case report and review. Ann Genet. 1988;31(1):36–38. [PubMed] [Google Scholar]
  16. Hobson J. A. Sleep and dreaming. J Neurosci. 1990 Feb;10(2):371–382. doi: 10.1523/JNEUROSCI.10-02-00371.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ivens A., Flavin N., Williamson R., Dixon M., Bates G., Buckingham M., Robert B. The human homeobox gene HOX7 maps to chromosome 4p16.1 and may be implicated in Wolf-Hirschhorn syndrome. Hum Genet. 1990 Apr;84(5):473–476. doi: 10.1007/BF00195823. [DOI] [PubMed] [Google Scholar]
  18. Lockwood D., Hecht F., Dowman C., Hecht B. K., Rizkallah T. H., Goodwin T. M., Allanson J. Chromosome subband 17p11.2 deletion: a minute deletion syndrome. J Med Genet. 1988 Nov;25(11):732–737. doi: 10.1136/jmg.25.11.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lupski J. R., de Oca-Luna R. M., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B. J., Saucedo-Cardenas O., Barker D. F., Killian J. M., Garcia C. A. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991 Jul 26;66(2):219–232. doi: 10.1016/0092-8674(91)90613-4. [DOI] [PubMed] [Google Scholar]
  20. Magenis R. E., Brown M. G., Allen L., Reiss J. De novo partial duplication of 17p [dup(17)(p12----p11.2)]: clinical report. Am J Med Genet. 1986 Jul;24(3):415–420. doi: 10.1002/ajmg.1320240304. [DOI] [PubMed] [Google Scholar]
  21. McAlpine P. J., Feasby T. E., Hahn A. F., Komarnicki L., James S., Guy C., Dixon M., Qayyum S., Wright J., Coopland G. Localization of a locus for Charcot-Marie-Tooth neuropathy type Ia (CMT1A) to chromosome 17. Genomics. 1990 Jul;7(3):408–415. doi: 10.1016/0888-7543(90)90175-t. [DOI] [PubMed] [Google Scholar]
  22. Middleton-Price H. R., Harding A. E., Monteiro C., Berciano J., Malcolm S. Linkage of hereditary motor and sensory neuropathy type I to the pericentromeric region of chromosome 17. Am J Hum Genet. 1990 Jan;46(1):92–94. [PMC free article] [PubMed] [Google Scholar]
  23. Nakamura Y., Leppert M., O'Connell P., Wolff R., Holm T., Culver M., Martin C., Fujimoto E., Hoff M., Kumlin E. Variable number of tandem repeat (VNTR) markers for human gene mapping. Science. 1987 Mar 27;235(4796):1616–1622. doi: 10.1126/science.3029872. [DOI] [PubMed] [Google Scholar]
  24. Nicholls R. D., Knoll J. H., Butler M. G., Karam S., Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature. 1989 Nov 16;342(6247):281–285. doi: 10.1038/342281a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Niebuhr E. The Cri du Chat syndrome: epidemiology, cytogenetics, and clinical features. Hum Genet. 1978 Nov 16;44(3):227–275. doi: 10.1007/BF00394291. [DOI] [PubMed] [Google Scholar]
  26. Overhauser J., Bengtsson U., McMahon J., Ulm J., Butler M. G., Santiago L., Wasmuth J. J. Prenatal diagnosis and carrier detection of a cryptic translocation by using DNA markers from the short arm of chromosome 5. Am J Hum Genet. 1989 Aug;45(2):296–303. [PMC free article] [PubMed] [Google Scholar]
  27. Patel P. I., Franco B., Garcia C., Slaugenhaupt S. A., Nakamura Y., Ledbetter D. H., Chakravarti A., Lupski J. R. Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. Am J Hum Genet. 1990 Apr;46(4):801–809. [PMC free article] [PubMed] [Google Scholar]
  28. Patel P. I., Garcia C., Montes de Oca-Luna R., Malamut R. I., Franco B., Slaugenhaupt S., Chakravarti A., Lupski J. R. Isolation of a marker linked to the Charcot-Marie-Tooth disease type IA gene by differential Alu-PCR of human chromosome 17-retaining hybrids. Am J Hum Genet. 1990 Dec;47(6):926–934. [PMC free article] [PubMed] [Google Scholar]
  29. Patil S. R., Bartley J. A. Interstitial deletion of the short arm of chromosome 17. Hum Genet. 1984;67(2):237–238. doi: 10.1007/BF00273011. [DOI] [PubMed] [Google Scholar]
  30. Popp D. W., Johnson C. P., Stratton R. F. An additional case of deletion 17p11.2. Am J Med Genet. 1987 Feb;26(2):493–495. doi: 10.1002/ajmg.1320260228. [DOI] [PubMed] [Google Scholar]
  31. Raeymaekers P., Timmerman V., De Jonghe P., Swerts L., Gheuens J., Martin J. J., Muylle L., De Winter G., Vandenberghe A., Van Broeckhoven C. Localization of the mutation in an extended family with Charcot-Marie-Tooth neuropathy (HMSN I). Am J Hum Genet. 1989 Dec;45(6):953–958. [PMC free article] [PubMed] [Google Scholar]
  32. Ray R., Rincon-Limas D., Wright R. A., Davis S. N., Lupski J. R., Patel P. I. Three polymorphisms at the D17S29 locus. Nucleic Acids Res. 1990 Aug 25;18(16):4958–4958. doi: 10.1093/nar/18.16.4958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schmickel R. D. Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr. 1986 Aug;109(2):231–241. doi: 10.1016/s0022-3476(86)80377-8. [DOI] [PubMed] [Google Scholar]
  34. Schrander-Stumpel C., Schrander J., Fryns J. P., Hamers G. Trisomy 17p due to a t(8;17) (p23;p11.2)pat translocation. Case report and review of the literature. Clin Genet. 1990 Feb;37(2):148–152. doi: 10.1111/j.1399-0004.1990.tb03492.x. [DOI] [PubMed] [Google Scholar]
  35. Smith A. C., McGavran L., Robinson J., Waldstein G., Macfarlane J., Zonona J., Reiss J., Lahr M., Allen L., Magenis E. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am J Med Genet. 1986 Jul;24(3):393–414. doi: 10.1002/ajmg.1320240303. [DOI] [PubMed] [Google Scholar]
  36. Stratton R. F., Dobyns W. B., Greenberg F., DeSana J. B., Moore C., Fidone G., Runge G. H., Feldman P., Sekhon G. S., Pauli R. M. Interstitial deletion of (17)(p11.2p11.2): report of six additional patients with a new chromosome deletion syndrome. Am J Med Genet. 1986 Jul;24(3):421–432. doi: 10.1002/ajmg.1320240305. [DOI] [PubMed] [Google Scholar]
  37. Tandan R., Taylor R., Adesina A., Sharma K., Fries T., Pendlebury W. Benign autosomal dominant syndrome of neuronal Charcot-Marie-Tooth disease, ptosis, parkinsonism, and dementia. Neurology. 1990 May;40(5):773–779. doi: 10.1212/wnl.40.5.773. [DOI] [PubMed] [Google Scholar]
  38. Vance J. M., Barker D., Yamaoka L. H., Stajich J. M., Loprest L., Hung W. Y., Fischbeck K., Roses A. D., Pericak-Vance M. A. Localization of Charcot-Marie-Tooth disease type 1a (CMT1A) to chromosome 17p11.2. Genomics. 1991 Apr;9(4):623–628. doi: 10.1016/0888-7543(91)90355-i. [DOI] [PubMed] [Google Scholar]
  39. Vance J. M., Nicholson G. A., Yamaoka L. H., Stajich J., Stewart C. S., Speer M. C., Hung W. Y., Roses A. D., Barker D., Pericak-Vance M. A. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol. 1989 May;104(2):186–189. doi: 10.1016/s0014-4886(89)80013-5. [DOI] [PubMed] [Google Scholar]
  40. Weber J. L., May P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989 Mar;44(3):388–396. [PMC free article] [PubMed] [Google Scholar]
  41. Williams C. A., Zori R. T., Stone J. W., Gray B. A., Cantu E. S., Ostrer H. Maternal origin of 15q11-13 deletions in Angelman syndrome suggests a role for genomic imprinting. Am J Med Genet. 1990 Mar;35(3):350–353. doi: 10.1002/ajmg.1320350308. [DOI] [PubMed] [Google Scholar]
  42. Wright E. C., Goldgar D. E., Fain P. R., Barker D. F., Skolnick M. H. A genetic map of human chromosome 17p. Genomics. 1990 May;7(1):103–109. doi: 10.1016/0888-7543(90)90524-x. [DOI] [PubMed] [Google Scholar]
  43. van Tuinen P., Rich D. C., Summers K. M., Ledbetter D. H. Regional mapping panel for human chromosome 17: application to neurofibromatosis type 1. Genomics. 1987 Dec;1(4):374–381. doi: 10.1016/0888-7543(87)90042-5. [DOI] [PubMed] [Google Scholar]